439 related articles for article (PubMed ID: 26798434)
1. MicroRNA in pancreatic ductal adenocarcinoma and its precursor lesions.
Hernandez YG; Lucas AL
World J Gastrointest Oncol; 2016 Jan; 8(1):18-29. PubMed ID: 26798434
[TBL] [Abstract][Full Text] [Related]
2. MicroRNAs as diagnostic markers for pancreatic ductal adenocarcinoma and its precursor, pancreatic intraepithelial neoplasm.
Xue Y; Abou Tayoun AN; Abo KM; Pipas JM; Gordon SR; Gardner TB; Barth RJ; Suriawinata AA; Tsongalis GJ
Cancer Genet; 2013 Jun; 206(6):217-21. PubMed ID: 23933230
[TBL] [Abstract][Full Text] [Related]
3. MicroRNAs Deregulated in Intraductal Papillary Mucinous Neoplasm Converge on Actin Cytoskeleton-Related Pathways That Are Maintained in Pancreatic Ductal Adenocarcinoma.
Fernandez-Castañer E; Vila-Casadesus M; Vila-Navarro E; Parra C; Lozano JJ; Castells A; Gironella M
Cancers (Basel); 2021 May; 13(10):. PubMed ID: 34069007
[TBL] [Abstract][Full Text] [Related]
4. MicroRNA-21 is induced early in pancreatic ductal adenocarcinoma precursor lesions.
du Rieu MC; Torrisani J; Selves J; Al Saati T; Souque A; Dufresne M; Tsongalis GJ; Suriawinata AA; Carrère N; Buscail L; Cordelier P
Clin Chem; 2010 Apr; 56(4):603-12. PubMed ID: 20093556
[TBL] [Abstract][Full Text] [Related]
5. hsa-miR-96 and hsa-miR-217 Expression Down-Regulates with Increasing Dysplasia in Pancreatic Intraepithelial Neoplasias and Intraductal Papillary Mucinous Neoplasms.
Chang X; Yu C; Li J; Yu S; Chen J
Int J Med Sci; 2017; 14(5):412-418. PubMed ID: 28539816
[No Abstract] [Full Text] [Related]
6. Novel Circulating miRNA Signatures for Early Detection of Pancreatic Neoplasia.
Vila-Navarro E; Duran-Sanchon S; Vila-Casadesús M; Moreira L; Ginès À; Cuatrecasas M; Lozano JJ; Bujanda L; Castells A; Gironella M
Clin Transl Gastroenterol; 2019 Apr; 10(4):e00029. PubMed ID: 31009404
[TBL] [Abstract][Full Text] [Related]
7. MicroRNAs as Indicators of Malignancy in Pancreatic Ductal Adenocarcinoma (PDAC) and Cystic Pancreatic Lesions.
Prinz C; Fehring L; Frese R
Cells; 2022 Aug; 11(15):. PubMed ID: 35954223
[TBL] [Abstract][Full Text] [Related]
8. MicroRNAs for Detection of Pancreatic Neoplasia: Biomarker Discovery by Next-generation Sequencing and Validation in 2 Independent Cohorts.
Vila-Navarro E; Vila-Casadesús M; Moreira L; Duran-Sanchon S; Sinha R; Ginés À; Fernández-Esparrach G; Miquel R; Cuatrecasas M; Castells A; Lozano JJ; Gironella M
Ann Surg; 2017 Jun; 265(6):1226-1234. PubMed ID: 27232245
[TBL] [Abstract][Full Text] [Related]
9. Precursor lesions of pancreatic cancer.
Yonezawa S; Higashi M; Yamada N; Goto M
Gut Liver; 2008 Dec; 2(3):137-54. PubMed ID: 20485640
[TBL] [Abstract][Full Text] [Related]
10. miRNA analysis in pancreatic cancer: the Dartmouth experience.
Abreu FB; Liu X; Tsongalis GJ
Clin Chem Lab Med; 2017 May; 55(5):755-762. PubMed ID: 28343174
[TBL] [Abstract][Full Text] [Related]
11. [Cystic pancreatic tumors: diagnostics and new biomarkers].
Berger AW; Seufferlein T; Kleger A
Chirurg; 2017 Nov; 88(11):905-912. PubMed ID: 28831506
[TBL] [Abstract][Full Text] [Related]
12. MicroRNA expression levels as diagnostic biomarkers for intraductal papillary mucinous neoplasm.
Wang L; Zheng J; Sun C; Wang L; Jin G; Xin L; Jin Z; Wang D; Li Z
Oncotarget; 2017 Aug; 8(35):58765-58770. PubMed ID: 28938594
[TBL] [Abstract][Full Text] [Related]
13. [MicroRNA expression pattern in intraductal papillary mucinous neoplasm].
Park YG; Lee KH; Lee JK; Lee KT; Choi DW; Choi SH; Heo JS; Jang KT; Lee EM; Kim JO; Min SY; Kim EJ
Korean J Gastroenterol; 2011 Oct; 58(4):190-200. PubMed ID: 22042419
[TBL] [Abstract][Full Text] [Related]
14. Investigating MicroRNA Expression Profiles in Pancreatic Cystic Neoplasms.
Lee LS; Szafranska-Schwarzbach AE; Wylie D; Doyle LA; Bellizzi AM; Kadiyala V; Suleiman S; Banks PA; Andruss BF; Conwell DL
Clin Transl Gastroenterol; 2014 Jan; 5(1):e47. PubMed ID: 24476997
[TBL] [Abstract][Full Text] [Related]
15. Micro-RNA Analysis of Pancreatic Cyst Fluid for Diagnosing Malignant Transformation of Intraductal Papillary Mucinous Neoplasm by Comparing Intraductal Papillary Mucinous Adenoma and Carcinoma.
Shirakami Y; Iwashita T; Uemura S; Imai H; Murase K; Shimizu M
J Clin Med; 2021 May; 10(11):. PubMed ID: 34067335
[TBL] [Abstract][Full Text] [Related]
16. Surveillance for pancreatic cancer in high-risk individuals.
Konings ICAW; Canto MI; Almario JA; Harinck F; Saxena P; Lucas AL; Kastrinos F; Whitcomb DC; Brand RE; Lachter J; Malleo G; Paiella S; Syngal S; Saltzman JR; Stoffel EM; van Hooft JE; Hruban RH; Poley JW; Fockens P; Goggins MG; Bruno MJ;
BJS Open; 2019 Oct; 3(5):656-665. PubMed ID: 31592073
[TBL] [Abstract][Full Text] [Related]
17. Serine protease inhibitor Kazal type 1 and epidermal growth factor receptor are expressed in pancreatic tubular adenocarcinoma, intraductal papillary mucinous neoplasm, and pancreatic intraepithelial neoplasia.
Ozaki N; Ohmuraya M; Ida S; Hashimoto D; Ikuta Y; Chikamoto A; Hirota M; Baba H
J Hepatobiliary Pancreat Sci; 2013 Aug; 20(6):620-7. PubMed ID: 23475261
[TBL] [Abstract][Full Text] [Related]
18. Pancreatic intraepithelial neoplasia-can we detect early pancreatic cancer?
Haugk B
Histopathology; 2010 Oct; 57(4):503-14. PubMed ID: 20875068
[TBL] [Abstract][Full Text] [Related]
19. Disease spectrum of intraductal papillary mucinous neoplasm with an associated invasive carcinoma invasive IPMN versus pancreatic ductal adenocarcinoma-associated IPMN.
Kang MJ; Lee KB; Jang JY; Kwon W; Park JW; Chang YR; Kim SW
Pancreas; 2013 Nov; 42(8):1267-74. PubMed ID: 24308063
[TBL] [Abstract][Full Text] [Related]
20. Precursor Lesions of Pancreatic Cancer.
Kim JY; Hong SM
Oncol Res Treat; 2018; 41(10):603-610. PubMed ID: 30269131
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
